Sr. Manager, Finance
Current• Manage two direct reports, overseeing the entire operating and capital expenditure consolidation process for the Genetic Testing Solutions (GTS) business unit• Owner of the GTS Monthly Business Review and Annual Operating Plan reporting packages• Member of the GTS leadership team, participating in weekly sync meetings to provide the business with insights, analysis, and visibility on financial performance and key market indicators• Lead finance partner for GTS R&D; developed mechanisms and new reporting for improving forecast accuracy and providing visibility to R&D leadership• Served as the Finance Lead for both the Amplitude (high-throughput COVID testing solution) and Global Health Equity (GHE) businesses, helping Amplitude grow to $1B in sales in only 2 years since product launch, and GHE to provide COVID testing for low- and middle-income countries• Consistently flex Opex to match testing demand on long-term resourcing needs for Clinical product R&D by participating in the NPI prioritization process with PMO and providing relevant analysis• Coach direct reports on identifying themes/insights, messaging to business partners, and how to solve complex reconciliation or accounting issues